Inactivation of SARS-CoV-2 by Commercially Available Disinfectants and Cleaners

被引:3
|
作者
Harada, Yu [1 ]
Amo, Hitomi [1 ]
Ono, Takuto [1 ]
Murai, Hiroki [1 ]
Sasaki, Tadahiro [2 ]
Shioda, Tatsuo [2 ]
Ikawa, Masahito [2 ]
Hirata, Yoshihiko [3 ]
机构
[1] Saraya Co Ltd, Biochem Lab, Saraya Microbiol Res Ctr, 309 Saito Bioincubator,7-7-15 Saitoasagi, Ibaraki, Osaka 5670085, Japan
[2] Osaka Univ, Res Inst Microbial Dis, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan
[3] Saraya Co Ltd, Biochem Lab, 24-12 Tamate Cho, Kashiwara, Osaka 5820028, Japan
关键词
SARS-CoV-2; COVID-19; Virucidal effect; EN; 14467;
D O I
10.4265/bio.27.223
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The recent emergence of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is a major burden for health care systems worldwide, and is a threat to our daily lives. Various effective ingredients against SARS-CoV-2 were already reported, however, since products contain various ingredients, it is also important to evaluate the effectiveness of commercially available disinfectants per se. In this study, the virucidal efficacy of forty-eight commercially available products were evaluated according to the standardized suspension method EN 14476 and the following results were obtained: Alcohol-based disinfectants, hand soaps, wet wipes, alkaline cleaners, quaternary ammonium compound sanitizers and oxygen bleach had great virucidal efficacy against SARS-CoV- 2. Enveloped viruses such as SARS-CoV-2 are among the most susceptible of pathogens to formulated microbicidal actives and detergents, but as the results of this study showed, it is also necessary to pay attention to the concentration at the time of use and the required contact time.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 50 条
  • [1] Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes
    Davies, Katherine
    Buczkowski, Hubert
    Welch, Stephen R.
    Green, Nicole
    Mawer, Damian
    Woodford, Neil
    Roberts, Allen D. G.
    Nixon, Peter J.
    Seymour, David W.
    Killip, Marian J.
    [J]. JOURNAL OF GENERAL VIROLOGY, 2021, 102 (04):
  • [2] Inactivation of Foot-and-Mouth Disease Virus by Commercially Available Disinfectants and Cleaners
    Harada, Yu
    Lekcharoensuk, Porntippa
    Furuta, Taro
    Taniguchi, Tooru
    [J]. BIOCONTROL SCIENCE, 2015, 20 (03) : 205 - 208
  • [3] Inactivation of SARS-CoV-2 by commercially available alcohol-based hand sanitizers
    Leslie, Rachel A.
    Zhou, S. Steve
    Macinga, David R.
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2021, 49 (03) : 401 - 402
  • [4] Validation of a commercially available SARS-CoV-2 serological immunoassay
    Meyer, B.
    Torriani, G.
    Yerly, S.
    Mazza, L.
    Calame, A.
    Arm-Vernez, I
    Zimmer, G.
    Agoritsas, T.
    Stirnemann, J.
    Spechbach, H.
    Guessous, I
    Stringhini, S.
    Pugin, J.
    Roux-Lombard, P.
    Fontao, L.
    Siegrist, C-A
    Eckerle, I
    Vuilleumier, N.
    Kaiser, L.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (10) : 1386 - 1394
  • [5] Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
    Weidner, Lisa
    Gaensdorfer, Simon
    Unterweger, Stephan
    Weseslindtner, Lukas
    Drexler, Camilla
    Farcet, Maria
    Witt, Volker
    Schistal, Elisabeth
    Schlenke, Peter
    Kreil, Thomas R.
    Jungbauer, Christof
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2020, 129
  • [6] Disinfectants against SARS-CoV-2: A Review
    Xiao, Shuqi
    Yuan, Zhiming
    Huang, Yi
    [J]. VIRUSES-BASEL, 2022, 14 (08):
  • [7] Rapid SARS-CoV-2 inactivation by commonly available chemicals on inanimate surfaces
    Gerlach, M.
    Wolff, S.
    Ludwig, S.
    Schaefer, W.
    Keiner, B.
    Roth, N. J.
    Widmer, E.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2020, 106 (03) : 633 - 634
  • [8] The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection
    Syre, Heidi
    Obreque, Marius Eduardo Bra
    Dalen, Ingvild
    Riis, Ase Garlov
    Berg, Ase
    Lohr, Iren Hoyland
    Sundal, Jon
    Kleppe, Lars Kare
    Vadla, May Sissel
    Lenning, Ole Bernt
    Olofsson, Jan Stefan
    Mohn, Kristin Greve-Isdahl
    Tondel, Camilla
    Blomberg, Bjorn
    Trieu, Mai Chi
    Langeland, Nina
    Cox, Rebecca Jane
    [J]. VIRUSES-BASEL, 2022, 14 (10):
  • [9] Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
    Chaves, Otavio Augusto
    Fintelman-Rodrigues, Natalia
    Wang, Xuanting
    Sacramento, Carolina Q.
    Temerozo, Jairo R.
    Ferreira, Andre C.
    Mattos, Mayara
    Pereira-Dutra, Filipe
    Bozza, Patricia T.
    Castro-Faria-Neto, Hugo Caire
    Russo, James J.
    Ju, Jingyue
    Souza, Thiago Moreno L.
    [J]. VIRUSES-BASEL, 2022, 14 (07):
  • [10] Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies
    Hashem, Anwar M.
    Alhabbab, Rowa Y.
    Algaissi, Abdullah
    Alfaleh, Mohamed A.
    Hala, Sharif
    Abujamel, Turki S.
    Elassouli, M-Zaki
    AL-Somali, Afrah A.
    Alofi, Fadwa S.
    Khogeer, Asim A.
    Alkayyal, Almohanad A.
    Mahmoud, Ahmad Bakur
    Almontashiri, Naif A. M.
    Pain, Arnab
    [J]. PATHOGENS, 2020, 9 (12): : 1 - 10